Sponsor:
Ottawa Heart Institute Research Corporation
Code:
NCT07368062
Conditions
Mental Health
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Interventions
Dexmedetomidine
Placebo
Brief summary:
Conditions
Mental Health
Study ID
NCT07368062
Start date
Mar 15, 2025
Status verified date
Jun, 2026
Completion date
Jun, 2028
Anticipated
Primary completion date
Dec, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
70 participants
Anticipated
Arms
Dexmedetomidine
Placebo
Interventions
Dexmedetomidine
Placebo
Primary outcome measure
Central contacts
Locations
University of Ottawa Heart Institute
Recruiting
Ottawa, Ontario, Canada, K1Y 4W7
Contacts
Sponsor
Ottawa Heart Institute Research Corporation
Last update posted
Jul 1, 2026
Last verified
Jun, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Ottawa Heart Institute Research Corporation on 2026-07-01.